List of insiders holdings for Decibel Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 2021-03-01 18:13:09 | 4,061,774 0 | 4,061,774 | Form 13D |
| Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner | 2022-02-14 17:03:00 | 3,139,685 0 | 3,139,685 | Form 13G |
| GV 2016 GP L.L.C. GV 2016 GP L.P. GV 2016 L.P. 10% Owner | 2022-02-14 12:30:53 | 1,636,258 0 | 1,636,258 | Form 13G |
| Foy Matthew Director 10% Owner | 2021-02-19 18:59:59 | 0 1,183,663 | 1,183,663 | Form 4 |
| GLAXOSMITHKLINE PLC Director | 2021-02-19 16:50:09 | 0 1,183,663 | 1,183,663 | Form 4 |
| Casdin Partners Master Fund L.P. 10% Owner | 2021-02-19 18:56:46 | 0 1,121,421 | 1,121,421 | Form 4 |
| GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. 10% Owner | 2021-02-17 19:45:57 | 0 819,631 | 819,631 | Form 4 |
| Schroder Adveq Technology IX S.C.S. Schroder Adveq Management Luxembourg Sarl Schroder Adveq cPl Global 2017 - 2019 C.V. Schroder Adveq cPl Global Management III L.P. 10% Owner | 2021-03-08 17:35:20 | 0 524,328 | 524,328 | Form 4 |
| GV 2017 GP L.L.C. GV 2017 GP L.P. GV 2017 L.P. 10% Owner | 2021-02-17 19:42:03 | 0 494,649 | 494,649 | Form 4 |
| Hu Cynthia W. General Counsel | 2021-08-18 16:55:03 | 150,000 0 | 150,000 | Form 4 |
| Vigliotta Ronald See Remarks | 2021-02-11 21:04:40 | 120,608 0 | 120,608 | Form 3 |
| Longevity Fund 2 LP 10% Owner | 2021-02-18 17:40:19 | 79,143 0 | 79,143 | Form 4 |
| Steven H. Holtzman Revocable Trust 10% Owner | 2021-02-11 21:16:00 | 67,786 0 | 67,786 | Form 3 |
| Leiderman Elisabeth Chief Financial Officer | 2022-02-28 16:37:54 | 52,500 0 | 52,500 | Form 4 |
| POON CHRISTINE A Director | 2021-02-16 17:37:13 | 20,000 0 | 20,000 | Form 4 |
| Exter Neil Director 10% Owner | 2022-06-21 18:45:25 | 10,000 0 | 10,000 | Form 4 |
| Thompson Peter A. Director 10% Owner | 2022-06-21 18:54:18 | 10,000 0 | 10,000 | Form 4 |
| REGENERON PHARMACEUTICALS INC. 10% Owner | 2023-09-27 16:05:18 | 100 0 | 100 | Form 13D |
| MURPHY JAMES B See Remarks | 2022-10-12 16:14:01 | 0 0 | 0 | Form 3 |
| Nochur Sara Director | 2023-09-25 16:24:04 | 0 0 | 0 | Form 4 |
| Kapusta Matthew C Director | 2023-09-25 16:24:47 | 0 0 | 0 | Form 4 |
| Reid Laurence See Remarks | 2023-09-25 16:25:59 | 0 0 | 0 | Form 4 |
| MCLAUGHLIN KEVIN F Director | 2023-09-25 16:28:12 | 0 0 | 0 | Form 4 |
| FINGER ALISON CECILY Director | 2023-09-25 16:29:33 | 0 0 | 0 | Form 4 |
| Lee John Jui-Jen Chief Development Officer | 2023-09-25 16:30:31 | 0 0 | 0 | Form 4 |
| Carson William H. Director | 2023-09-25 16:32:58 | 0 0 | 0 | Form 4 |
| Trask Anna Chief People Officer | 2023-09-25 16:35:59 | 0 0 | 0 | Form 4 |